UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 7, 2026
Atrium Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-43008 39-4639499
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-36206
SOLAI Limited
428 South Seiberling Street
Akron, Ohio 44306
United States of America
+1 (346) 204-8537
Indicate by check mark whether the registrant files or will file annual... (continue reading...)
ATTACHMENTS / EXHIBITS
internalcontrolrpt_wasd_waif.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-42527
Basel Medical Group Ltd
6 Napier Road,
Unit #02-10/11 Gleneagles Medical Centre
Singapore 258499
(Address of principal executive office)
Indicate by check... (continue reading...)
This pricing supplement, which is not complete and may be changed, relates to an effective Registration Statement under the Securities Act of 1933. This pricing supplement and the accompanying product supplement, prospectus supplement and prospectus are not an offer to sell these Notes in any country or jurisdiction where such an offer would not be permitted.
BofA Finance LLC $--
... (continue reading...)
More SEC Filings
View Older Stories-
Form N-CEN Legg Mason Global Asset For: Jul 31
-
Form 8-K Transocean Ltd. For: Oct 09
-
Form 8-K PRUDENTIAL FINANCIAL For: Oct 09
-
Form 425 GigCapital8 Corp. Filed by: GigCapital8 Corp.
-
Form F-4 Scancell Holdings plc
-
Form 8-K GigCapital8 Corp. For: Oct 08
-
Form C Ronald Isley Liquid Gold
-
Form 4 CHECK POINT SOFTWARE For: Aug 05 Filed by: SHWED GIL
-
Form S-1/A CITY THERAPEUTICS, INC.
-
Form SCHEDULE 13D/A Gogoro Inc. Filed by: Gold Sino Assets Ltd
-
Form 424B2 BofA Finance LLC
-
Form EFFECT DarkIris Inc.
-
Form 424B2 PEPSICO INC
-
Form EFFECT TOP Financial Group Ltd
-
Form 425 RXO, Inc. Filed by: C. H. ROBINSON WORLDWIDE, INC.
-
Form RW Alzamend Neuro, Inc.
-
Form SCHEDULE 13D/A Melco Resorts & Entertai Filed by: Melco International Development LTD
-
Form EFFECT GEN Restaurant Group,
-
Form EFFECT Retension Pharmaceutical
-
Form 8-K Avalanche Treasury Corp For: Oct 07
-
Form EFFECT Nexera Technologies Ltd
-
Form 424B2 BARCLAYS BANK PLC
-
Form 6-K Chilwa Minerals Ltd For: Oct 09
-
Form 3 Hub Group, Inc. For: Oct 01 Filed by: Malik Thaddeus J.
-
Form 6-K ALTERITY THERAPEUTICS For: Oct 31
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form 6-K Caledonia Mining Corp For: Oct 09
-
Form 10-Q Huineng Technology Corp For: Aug 31
-
Form 424B2 BARCLAYS BANK PLC
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form EFFECT Bio Green Med Solution,
-
Form EFFECT FRANKLIN MUNICIPAL OPPOR
-
Form EFFECT TPG Mortgage Investment
-
Form 8-K HUMANA INC For: Oct 09
-
Form 4 Sea Ltd For: Oct 07 Filed by: Wang Yanjun
-
Form QUALIF RYSE Inc.
-
Form FWP INNOVATIVE INDUSTRIAL Filed by: INNOVATIVE INDUSTRIAL PROPERTIES INC
-
Form D/A PFDPRO MANAGEMENT FUND,
-
Form EFFECT FullPAC, Inc.
-
Form EFFECT SmartTrust 763
-
Form D DPEG Kanwa, LP
-
Form EFFECT FRANKLIN MANAGED MUNICIP
-
Form EFFECT TRex Bio, Inc.
-
Form EFFECT ECOMINAS CORP.
-
Form 6-K YPF SOCIEDAD ANONIMA For: Oct 08
-
Form D Pinnacle RE Services
-
Form 13F-HR McNaughton Wealth Manage For: Sep 30
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 424B2 BofA Finance LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
